|
|
Volumn 21, Issue 2, 2005, Pages
|
|
Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RECOMBINANT ERYTHROPOIETIN;
PLACEBO;
ADULT;
ANEMIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
FATIGUE;
FEMALE;
FUNCTIONAL ASSESSMENT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE REGRESSION;
QUALITY OF LIFE;
RACE DIFFERENCE;
RANDOMIZED CONTROLLED TRIAL;
CHEMICALLY INDUCED DISORDER;
DOUBLE BLIND PROCEDURE;
MIDDLE AGED;
MULTICENTER STUDY;
NEOPLASM;
PATHOPHYSIOLOGY;
STATISTICAL MODEL;
ANEMIA;
ANTINEOPLASTIC AGENTS;
DOUBLE-BLIND METHOD;
EPOETIN ALFA;
FEMALE;
HUMANS;
LINEAR MODELS;
MALE;
MIDDLE AGED;
NEOPLASMS;
PLACEBOS;
QUALITY OF LIFE;
|
|
EID: 24044463262
PISSN: 01419951
EISSN: None
Source Type: Journal
DOI: 10.1185/174234305X13798 Document Type: Article |
|
Times cited : (4)
|
|
References (5)
|
